NYSE:ANVS

Annovis Bio Stock Insider Trading

etoro logo Buy ANVS
*Your capital is at risk
$1.86
+0.0400 (+2.20%)
At Close: Jun 02, 2026

Annovis Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 4.13M and sold 66K ANVS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 4.13M shares
Sell 66K shares
92% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Aug 29, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 000
Value: $11.5K
Aug 29, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 000
Value: $11.5K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 1 100
Value: $3K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 545
Value: $14.3K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 283
Value: $13.7K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 6 717
Value: $17.5K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 6 717
Value: $17.5K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 283
Value: $13.7K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 545
Value: $14.3K
Aug 19, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 1 100
Value: $3K
Jun 16, 2025
Buy
Common Stock
A-Award
Walsh Andrew
Vice President, Finance
CEO / President 500
Value: $1K
Jun 16, 2025
Buy
Common Stock
A-Award
Walsh Andrew
Vice President, Finance
CEO / President 500
Value: $1K
Jun 13, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 1
Value: $3
Jun 13, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 25 000
Value: $70.0K
Jun 13, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 25 000
Value: $70.0K
Jun 13, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 1
Value: $3
Jun 10, 2025
Buy
Common Stock
A-Award
Mccarthy Reid
Director
Director 2 000
Value: $6K
Jun 10, 2025
Buy
Common Stock
A-Award
Mccarthy Reid
Director
Director 2 000
Value: $6K
Jun 04, 2025
Buy
Common Stock
A-Award
Maccecchini Maria-luisa
President & CEO
CEO / President 46 000
Value: $155.0K
Jun 04, 2025
Buy
Common Stock
A-Award
Maccecchini Maria-luisa
President & CEO
CEO / President 46 000
Value: $155.0K
May 29, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 000
Value: $12.2K
May 29, 2025
Buy
Common Stock
A-Award
Hoffman Michael B
Director
Director 5 000
Value: $12.2K
May 09, 2025
Buy
Option (Right to Buy)
Walsh Andrew
Vice President, Finance
CEO / President 10 000
Value: $60.7K
May 09, 2025
Buy
Option (Right to Buy)
Walsh Andrew
Vice President, Finance
CEO / President 4 000
Value: $24.0K
May 09, 2025
Buy
Option (Right to Buy)
Walsh Andrew
Vice President, Finance
CEO / President 4 000
Value: $24.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ANNOVIS BIO, INC.
Annovis Bio
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE